Rapcabtagene autoleucel
CYTB323I12201
Phase 2 mab active
Quick answer
Rapcabtagene autoleucel for ANCA Associated Vasculitis (AAV) is a Phase 2 program (mab) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- ANCA Associated Vasculitis (AAV)
- Phase
- Phase 2
- Modality
- mab
- Status
- active